Pure Global
NCT06383936

FAldini Sport Total Joint Arthroplasty-Knee II

FAldini Sport Total Joint Arthroplasty-Knee II: Toward Rehabilitation of Sports Activity Following Total Knee Arthroplasty
Istituto Ortopedico Rizzoli·ClinicalTrials.gov·procedureNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Knee Osteoarthritis
Drug/Device/Intervention
intensive rehabilitation after uncemented TKA
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Istituto Ortopedico Rizzoli
Timeline & enrollment
Phase
N/A
Start date
Apr 20, 2024
End date
Dec 31, 2025
Enrollment
20 participants
Primary outcome

number of patients returning to sports activities assessed by questionnaire,clinical and functional outcomes measured as the variation in the Knee Society Score

Summary

The majority of patients undergoing total knee arthroplasty are elderly individuals with low
 functional demands, aiming to alleviate pain. However, there exists a subgroup of younger
 patients, under the age of 65, with higher functional demands. The purpose of this study is
 to evaluate the return to sports activities in this patient group following a non-cemented
 total knee arthroplasty procedure and a specific rehabilitation protocol. The investigators
 expect that with the use of non-cemented prostheses and a specific rehabilitation protocol,
 many of these patients will safely resume sports activities.

ICD-10 classifications
Chronic instability of kneeGonarthrosis [arthrosis of knee]Other hypertrophic osteoarthropathyDislocation, sprain and strain of joints and ligaments of kneePatellofemoral disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06383936
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06383936 through Pure Global AI's free database. This phase not specified trial is sponsored by Istituto Ortopedico Rizzoli and is currently Not yet recruiting. The study focuses on Knee Osteoarthritis. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.